Biocryst Pharma Inc (BCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2000 | 12-1999 | 12-1998 | 12-1997 | 12-1996 | |
| Sales | 7,661 | 5,329 | 7,620 | 2,693 | 2,652 |
| Gross Profit | 7,661 | 5,329 | 7,620 | 2,693 | 2,652 |
| Operating Expenses | 13,015 | 10,421 | 12,390 | 0 | 10,250 |
| Operating Income | -5,354 | -5,093 | -4,770 | 2,693 | -7,598 |
| Interest Expense | 3 | 5 | 10 | 52 | 100 |
| Other Income | -133 | -200 | 0 | -13,260 | 0 |
| Pre-tax Income | -5,490 | -5,298 | -4,780 | -10,619 | -7,698 |
| Net Income Continuous | -5,490 | -5,298 | -4,785 | -10,619 | -7,698 |
| Net Income | $-11,578 | $-5,298 | $-4,780 | $-10,619 | $-7,698 |
| EPS Basic Total Ops | -0.66 | -0.34 | -0.34 | -0.77 | -0.69 |
| EPS Basic Continuous Ops | -0.31 | -0.34 | -0.34 | -0.77 | -0.69 |
| EPS Diluted Total Ops | -0.66 | -0.34 | -0.34 | -0.77 | -0.69 |
| EPS Diluted Continuous Ops | -0.31 | -0.34 | -0.34 | -0.77 | -0.69 |
| EBITDA(a) | $-4,684 | $-4,568 | $-4,250 | $2,693 | $-7,074 |